The Cigna Corporation, under the ticker CI, showcases a robust blend of diversified healthcare solutions. As a key player in the insurance landscape, the company exhibits a solid operating model, albeit challenges in debt-to-equity. Here’s an in-depth look at its fundamentals, historical ratings, and analyst opinions.
Cigna Corporation retains a commendable fundamental rating with specific strengths and weaknesses.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 3 |
Review the progression of key financial metrics over time.
| Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | 3 | 5 | 4 | 3 | 1 | 3 | 3 |
| Previous | 0 | 5 | 4 | 3 | 1 | 3 | 3 |
Projected stock price evaluations emphasize growth potential.
| High | Low | Median | Consensus |
|---|---|---|---|
| $400 | $302 | $340 | $340.91 |
Consistent Buy recommendations suggest a positive outlook for Cigna.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 28 | |
| Hold | 10 | |
| Sell | 0 | |
| Strong Sell | 0 |
Cigna Corporation demonstrates a promising financial foundation with noted strengths in cash-flow management and return on equity. Despite challenges with debt levels, the strategic positioning in healthcare facilitates a positive growth trajectory. Analyst recommendations underscore a favorable sentiment, however, market volatility demands cautious optimism. Investors should weigh potential risks against the competitive advantage in the medical insurance sector.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.